Companion Diagnostics Banner

May 18-19

Companion Diagnostics Implementation

Companion Diagnostics: Pot of Gold or Money Pit

Steven Gutman, M.D., MBA, Strategic Advisor, Myraqa/Illumina

Blood-Based Companion Diagnostics

Ron Mazumder, Ph.D., MBA, Global Head, R&D and Operations, Janssen Diagnostics, Janssen Pharmaceutical Companies of Johnson & Johnson

Talk Title to be Announced

Aaron Schetter, Ph.D., Senior Staff Fellow, Center for Devices and Radiological Health, US Food and Drug Administration

Companion Diagnostics beyond Oncology

Talk Title to be Announced

Brian Abbott, Senior Director, Regulatory Affairs, AstraZeneca

Beyond Oncology: Implementing Precision Medicine and Companion Diagnostics Principles in Other Therapeutic Areas – A Case Study

Marielena Mata, Ph.D., Head of Precision Medicine and Companion Diagnostics, GlaxoSmithKline

Partnering and Collaborations to Drive Innovation

Talk Title to be Announced

Yiu-Lian Fong, Ph.D., MBA, Senior Director, Diagnostic Innovation, Johnson & Johnson Innovation

Partnering for Personalized Medicine

Nicole D. St Jean, MBA, Personalized Healthcare, Corporate Business Development, Global Product & Portfolio Strategy, AstraZeneca

Strategic Partnerships for CDx – Challenges and Opportunities

Daniel Forler, Ph.D., Alliance Management, Global External Innovation & Alliances, Bayer AG